| 000 | 01933 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515231945.0 | ||
| 264 | 0 | _c20101015 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1875-2128 | ||
| 024 | 7 |
_a10.1016/j.acvd.2010.04.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDetaint, Delphine | |
| 245 | 0 | 0 |
_aRationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. _h[electronic resource] |
| 260 |
_bArchives of cardiovascular diseases _cMay 2010 |
||
| 300 |
_a317-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAortic Aneurysm _xdiagnostic imaging |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLosartan _xtherapeutic use |
| 650 | 0 | 4 |
_aMarfan Syndrome _xcomplications |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPlacebo Effect |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUltrasonography |
| 700 | 1 | _aAegerter, Philippe | |
| 700 | 1 | _aTubach, Florence | |
| 700 | 1 | _aHoffman, Isabelle | |
| 700 | 1 | _aPlauchu, Henri | |
| 700 | 1 | _aDulac, Yves | |
| 700 | 1 | _aFaivre, Laurence Olivier | |
| 700 | 1 | _aDelrue, Marie-Ange | |
| 700 | 1 | _aCollignon, Patrick | |
| 700 | 1 | _aOdent, Sylvie | |
| 700 | 1 | _aTchitchinadze, Maria | |
| 700 | 1 | _aBouffard, Catherine | |
| 700 | 1 | _aArnoult, Florence | |
| 700 | 1 | _aGautier, Mathieu | |
| 700 | 1 | _aBoileau, Catherine | |
| 700 | 1 | _aJondeau, Guillaume | |
| 773 | 0 |
_tArchives of cardiovascular diseases _gvol. 103 _gno. 5 _gp. 317-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.acvd.2010.04.008 _zAvailable from publisher's website |
| 999 |
_c19962548 _d19962548 |
||